PD Dr. Carol-Immanuel Geppert

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Medizinische Fakultät Institute of Pathology

Bedeutung von HPV-Status und p16 für die Prognose des Peniskarzinoms (2023) Mink JN, Khalmurzaev O, Pryalukhin A, Hölters S, Geppert CI, Lohse S, Bende K, et al. Journal article Management of Cervical Intraepithelial Neoplasia in Pregnant Women (2023) Stübs F, Koch MC, Dietl A, Schulmeyer C, Behrens A, Seibold A, Adler W, et al. Journal article Tumor–Stroma Ratio in Colorectal Cancer—Comparison between Human Estimation and Automated Assessment (2023) Firmbach D, Benz M, Kuritcyn P, Bruns V, Lang-Schwarz C, Stübs F, Merkel S, et al. Journal article Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression (2023) Hartmann P, Trufa D, Hohenberger K, Tausche P, Trump S, Mittler S, Geppert CI, et al. Journal article The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer? (2023) Trumet L, Weber M, Hahn A, Kunater L, Geppert CI, Glajzer J, Struckmeier AK, et al. Journal article The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer (2023) Ranjan RA, Muenzner JK, Kunze P, Geppert CI, Rübner M, Hübner H, Fasching P, et al. Journal article Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association (2023) Kneis B, Wirtz S, Weber K, Denz A, Gittler M, Geppert CI, Brunner M, et al. Journal article Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer (2023) Foersch S, Glasner C, Woerl AC, Eckstein M, Wagner DC, Schulz S, Kellers F, et al. Journal article A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma (2023) Spoerl S, Erber R, Gerken M, Taxis J, Ludwig N, Nieberle F, Biermann N, et al. Journal article Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial (2023) Rath T, Atreya R, Bodenschatz J, Uter W, Geppert CI, Vitali F, Fischer S, et al. Journal article